Modulation of in vitro Osteoclast Activity Mediated by Different Doses of Parathyroid Hormone

Tweet about this on TwitterShare on FacebookEmail this to someoneShare on Google+

Fernanda Ginani; Haroldo Gurgel Mota-Filho; Mardem Portela e Vasconcelos Barreto & Carlos Augusto Galvão Barboza


Bone remodeling is a process regulated by the interaction between cells and various molecules such as parathyroid hormone (PTH). The aim of the study was to evaluate the effect of different doses of PTH on osteoclast activity in a culture model of bone organs. Six-day-old male C57BL/6 mice (n=14) were euthanized and the calvariae were dissected and sectioned in the middle, keeping the periosteal and endosteal. The bone fragments were divided into three groups: Group I (control - without adding PTH), Group II (addition of 3 nM PTH) and Group III (30 nM PTH), all cultured in aMEM for up to 72 h osteoclast activity was evaluated by biochemical quantification of calcium released in the culture medium at intervals of 24, 48, and 72 h and by histomorphometric analysis of bone resorption lacunae at 72 h our results show that group II exhibited significantly higher values of calcium levels in the medium compared to group I (p<0.05) in all intervals, also being higher for group III at 24 hours (p<0.05). Group II promoted a greater demineralization area (22068 ± 2193 mm2) than those found in group I (2084 ± 38 mm2) and group III (8952 ± 246 mm2), with statistically significant difference (p<0.001) among all groups. We concluded that in culture model of bone organs PTH promotes higher bone resorption when administered in lower doses.

KEY WORDS: Parathyroid hormone; Osteoclast; Bone remodeling; Organ culture techniques.

How to cite this article

GINANI, F.; MOTA-FILHO, H. G.; VASCONCELOS BARRETO, M. P. & BARBOZA, C. A. G. Modulation of in vitro osteoclast activity mediated by different doses of parathyroid hormone. Int. J. Morphol., 35(2):584-588, 2017.